性吧导航

Tip60鈥檚 novel function is a critical piece in the brain puzzle that brings us one step closer to understanding the big picture behind Alzheimer鈥檚 Disease. Image was generated using BioRender.

Researchers from 性吧导航 have uncovered a novel regulatory mechanism in the brain that is essential for making the right kinds of proteins that promote healthy brain function, and its malfunctioning may be an early contributor of the development of Alzheimer鈥檚 disease.

Brain cells are continuously undergoing changes in response to environmental stimuli and to record new memories. Such complex brain capability relies on the ability of brain cells to generate different functional variants of the same protein using a process known as alternative RNA splicing.

Recent studies have reported defects in RNA splicing of genes in the brains of Alzheimer鈥檚 patients, which has led to the conclusion that splicing disruptions are considered. Causes for these splicing disruptions in the brain are still unknown, which has hindered the development of treatments focused on this defect.

The team led by Akanksha Bhatnagar, a PhD student, and Felice Elefant, PhD, a professor, who are biology researchers in Drexel鈥檚 College of Arts and Sciences, is the first to uncover the role of the Tip60 enzyme in binding to certain RNA in the brain to control how they are spliced.

This function is particularly important, the researchers suggest, because such RNA splicing ultimately generates the protein diversity required for learning and memory and the majority of RNA that Tip60 binds to are encoded by genes implicated in Alzheimer鈥檚 disease progression.   

A 2018 Drexel study by showed that restoration of the enzyme Tip60 created a balancing of the enzymes in the brain and reversed symptoms in an Alzheimer鈥檚 model system. Building on that study, Elefant, Bhatnagar, and their team 鈥� whose findings were published in the Journal of Neuroscience 鈥� discovered that Tip60 doesn鈥檛 just regulate gene activation to make RNA, it also regulates the way RNA is spliced to generate diverse protein variants, which has been shown to contribute to the reversal of Alzheimer鈥檚 symptoms.

鈥淲e have previously shown that Tip60 enzyme levels are depleted in Alzheimer鈥檚 disease brains and this depletion results in some genes getting inactivated. However, with this new RNA splicing function, we now show Tip60 is also not present to bind to the RNA to allow for appropriate splicing in the brain and may be causing some of the splicing defects observed in Alzheimer鈥檚 disease,鈥� said Elefant.

The researchers found that restoring depleted amounts of Tip60 in Alzheimer鈥檚 models, not only rescues gene activation, but also partially protects against splicing disruptions 鈥� demonstrating that the Tip60 enzyme can be a drug target to protect against two different processes that go awry in Alzheimer鈥檚.